866-997-4948(US-Canada Toll Free)

Global Anti-inflammatory Drugs Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 97 Pages

This report studies the global market size of Anti-inflammatory Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-inflammatory Drugs in these regions.
This research report categorizes the global Anti-inflammatory Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Anti-inflammatory Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Anti-inflammatory Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Anti-inflammatory Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-inflammatory Drugs include
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Bayer
Novacap
Kopran Ltd.

Market Size Split by Type
by Types
Over-The-Counter
Prescription Medications
by Products
Aspirin,
Ibuprofen
Naproxen
COX-2 Inhibitors
Other
by Form
Regular Tablet
Delayed-Release Tablet
Liquid
Topical Cream
Paste
Injection
Market Size Split by Application
Skin Rashes
Chronic Arthritis
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Anti-inflammatory Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Anti-inflammatory Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-inflammatory Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-inflammatory Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anti-inflammatory Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-inflammatory Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-inflammatory Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Anti-inflammatory Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Type
1.4.2 Over-The-Counter
1.4.3 Prescription Medications
1.5 Market by Application
1.5.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Application
1.5.2 Skin Rashes
1.5.3 Chronic Arthritis
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Anti-inflammatory Drugs Market Size
2.1.1 Global Anti-inflammatory Drugs Revenue 2016-2025
2.1.2 Global Anti-inflammatory Drugs Sales 2016-2025
2.2 Anti-inflammatory Drugs Growth Rate by Regions
2.2.1 Global Anti-inflammatory Drugs Sales by Regions
2.2.2 Global Anti-inflammatory Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Anti-inflammatory Drugs Sales by Manufacturers
3.1.1 Anti-inflammatory Drugs Sales by Manufacturers
3.1.2 Anti-inflammatory Drugs Sales Market Share by Manufacturers
3.1.3 Global Anti-inflammatory Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti-inflammatory Drugs Revenue by Manufacturers
3.2.1 Anti-inflammatory Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Anti-inflammatory Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Anti-inflammatory Drugs Price by Manufacturers
3.4 Anti-inflammatory Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-inflammatory Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Anti-inflammatory Drugs Sales by Type
4.2 Global Anti-inflammatory Drugs Revenue by Type
4.3 Anti-inflammatory Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Anti-inflammatory Drugs Breakdown Data by Application

6 North America
6.1 North America Anti-inflammatory Drugs by Countries
6.1.1 North America Anti-inflammatory Drugs Sales by Countries
6.1.2 North America Anti-inflammatory Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-inflammatory Drugs by Type
6.3 North America Anti-inflammatory Drugs by Application
6.4 North America Anti-inflammatory Drugs by Company

7 Europe
7.1 Europe Anti-inflammatory Drugs by Countries
7.1.1 Europe Anti-inflammatory Drugs Sales by Countries
7.1.2 Europe Anti-inflammatory Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-inflammatory Drugs by Type
7.3 Europe Anti-inflammatory Drugs by Application
7.4 Europe Anti-inflammatory Drugs by Company

8 Asia Pacific
8.1 Asia Pacific Anti-inflammatory Drugs by Countries
8.1.1 Asia Pacific Anti-inflammatory Drugs Sales by Countries
8.1.2 Asia Pacific Anti-inflammatory Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-inflammatory Drugs by Type
8.3 Asia Pacific Anti-inflammatory Drugs by Application
8.4 Asia Pacific Anti-inflammatory Drugs by Company

9 Central & South America
9.1 Central & South America Anti-inflammatory Drugs by Countries
9.1.1 Central & South America Anti-inflammatory Drugs Sales by Countries
9.1.2 Central & South America Anti-inflammatory Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-inflammatory Drugs by Type
9.3 Central & South America Anti-inflammatory Drugs by Application
9.4 Central & South America Anti-inflammatory Drugs by Company

10 Middle East and Africa
10.1 Middle East and Africa Anti-inflammatory Drugs by Countries
10.1.1 Middle East and Africa Anti-inflammatory Drugs Sales by Countries
10.1.2 Middle East and Africa Anti-inflammatory Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-inflammatory Drugs by Type
10.3 Middle East and Africa Anti-inflammatory Drugs by Application
10.4 Middle East and Africa Anti-inflammatory Drugs by Company

11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.1.4 Anti-inflammatory Drugs Product Description
11.1.5 Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.2.4 Anti-inflammatory Drugs Product Description
11.2.5 Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.3.4 Anti-inflammatory Drugs Product Description
11.3.5 Recent Development
11.4 Merck & Co.
11.4.1 Merck & Co. Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.4.4 Anti-inflammatory Drugs Product Description
11.4.5 Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.5.4 Anti-inflammatory Drugs Product Description
11.5.5 Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.6.4 Anti-inflammatory Drugs Product Description
11.6.5 Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.7.4 Anti-inflammatory Drugs Product Description
11.7.5 Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.8.4 Anti-inflammatory Drugs Product Description
11.8.5 Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.9.4 Anti-inflammatory Drugs Product Description
11.9.5 Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Anti-inflammatory Drugs
11.10.4 Anti-inflammatory Drugs Product Description
11.10.5 Recent Development
11.11 Bayer
11.12 Novacap
11.13 Kopran Ltd.

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Anti-inflammatory Drugs Raw Material
13.1.2 Anti-inflammatory Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Anti-inflammatory Drugs
Figure Global Anti-inflammatory Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Anti-inflammatory Drugs Production Market Share by Types (Product Category) in 2017
Figure Over-The-Counter Product Picture
Table Major Manufacturers of Over-The-Counter
Figure Prescription Medications Product Picture
Table Major Manufacturers of Prescription Medications
Table Global Anti-inflammatory Drugs Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Skin Rashes
Figure Chronic Arthritis
Figure Other
Figure Anti-inflammatory Drugs Report Years Considered
Figure Global Anti-inflammatory Drugs Market Size 2016-2025 (Million US$)
Figure Global Anti-inflammatory Drugs Sales 2016-2025 (K Units)
Table Global Anti-inflammatory Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Anti-inflammatory Drugs Sales by Regions 2016-2025 (K Units)
Table Global Anti-inflammatory Drugs Sales Market Share by Regions 2016-2025
Figure Global Anti-inflammatory Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Anti-inflammatory Drugs Sales Market Share by Regions
Table Global Anti-inflammatory Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Anti-inflammatory Drugs Revenue Market Share by Regions 2016-2025
Figure Global Anti-inflammatory Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Anti-inflammatory Drugs Revenue Market Share by Regions
Table Global Anti-inflammatory Drugs Sales by Manufacturers (2016-2018) (K Units)
Table Global Anti-inflammatory Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Anti-inflammatory Drugs Sales Share by Manufacturers in 2017
Table Anti-inflammatory Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Anti-inflammatory Drugs Revenue Share by Manufacturers (2016-2018)
Figure Anti-inflammatory Drugs Value Share by Manufacturers in 2017
Table Global Anti-inflammatory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Anti-inflammatory Drugs Price (2016-2018) (USD/Unit)
Table Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-inflammatory Drugs Product Category
Table Date of International Manufacturers Enter into Anti-inflammatory Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
Table Global Anti-inflammatory Drugs Sales Share by Type (2016-2025)
Figure Global Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
Figure Global Anti-inflammatory Drugs Sales Market Share by Type in 2017
Table Global Anti-inflammatory Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Anti-inflammatory Drugs Revenue Share by Type (2016-2025)
Figure Global Anti-inflammatory Drugs Revenue Market Share by Type (2016-2025)
Figure Global Anti-inflammatory Drugs Revenue Market Share by Type in 2017
Table Anti-inflammatory Drugs Price by Type 2013-2018 (USD/Unit)
Table Global Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
Table Global Anti-inflammatory Drugs Sales Share by Application (2016-2025)
Figure Global Sales Anti-inflammatory Drugs Market Share by Application (2016-2025)
Figure Global Sales Anti-inflammatory Drugs Market Share by Application (2016-2025)
Figure North America Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
Figure North America Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
Table North America Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Anti-inflammatory Drugs Sales Market Share by Countries
Table North America Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Anti-inflammatory Drugs Revenue Market Share by Countries
Figure United States Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure United States Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Canada Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
Table North America Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Anti-inflammatory Drugs Market Share by Type
Table North America Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
Table North America Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Anti-inflammatory Drugs Market Share by Application
Table North America Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
Table North America Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
Figure North America Anti-inflammatory Drugs Sales Market Share by Company in 2017
Figure Europe Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Europe Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
Table Europe Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Anti-inflammatory Drugs Sales Market Share by Countries
Table Europe Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Anti-inflammatory Drugs Revenue Market Share by Countries
Figure Germany Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Germany Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (K Units)
Figure France Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure France Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (K Units)
Figure UK Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure UK Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Italy Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Russia Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
Table Europe Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Anti-inflammatory Drugs Market Share by Type
Table Europe Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
Table Europe Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Anti-inflammatory Drugs Market Share by Application
Table Europe Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
Table Europe Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
Figure Europe Anti-inflammatory Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Anti-inflammatory Drugs Sales Market Share by Countries
Table Asia Pacific Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Anti-inflammatory Drugs Revenue Market Share by Countries
Figure China Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure China Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Japan Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Korea Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure India Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Australia Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
Table Asia Pacific Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Anti-inflammatory Drugs Market Share by Type
Table Asia Pacific Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
Table Asia Pacific Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Anti-inflammatory Drugs Market Share by Application
Table Asia Pacific Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
Table Asia Pacific Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Anti-inflammatory Drugs Sales Market Share by Company in 2017
Figure Central & South America Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
Table Central & South America Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Anti-inflammatory Drugs Sales Market Share by Countries
Table Central & South America Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Anti-inflammatory Drugs Revenue Market Share by Countries
Figure Brazil Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
Table Central & South America Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Anti-inflammatory Drugs Market Share by Type
Table Central & South America Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
Table Central & South America Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Anti-inflammatory Drugs Market Share by Application
Table Central & South America Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
Table Central & South America Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Anti-inflammatory Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Anti-inflammatory Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Anti-inflammatory Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Anti-inflammatory Drugs Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Countries
Table Middle East and Africa Anti-inflammatory Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Countries
Figure GCC Countries Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Anti-inflammatory Drugs Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Anti-inflammatory Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Anti-inflammatory Drugs Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Anti-inflammatory Drugs Market Share by Type
Table Middle East and Africa Anti-inflammatory Drugs Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Anti-inflammatory Drugs Market Share by Application
Table Middle East and Africa Anti-inflammatory Drugs Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Company in 2017
Table Roche Company Details
Table Roche Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Roche Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Abbott Laboratories Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck & Co. Recent Development
Table Pfizer Company Details
Table Pfizer Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Amgen Company Details
Table Amgen Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Amgen Recent Development
Table Sanofi Company Details
Table Sanofi Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Novartis Company Details
Table Novartis Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Eli Lilly Recent Development
Table Amgen Company Details
Table Amgen Anti-inflammatory Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Amgen Recent Development
Table Bayer Company Details
Table Novacap Company Details
Table Kopran Ltd. Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Anti-inflammatory Drugs Value Chain
Table Typical Suppliers of Key Anti-inflammatory Drugs Raw Material
Table Anti-inflammatory Drugs Customers List
Table Anti-inflammatory Drugs Sales Channels
Table Anti-inflammatory Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *